Tina Susan Nova - 04 Jun 2026 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Reporting relationship
Director
Issuer ticker
AUPH
Reported as of
04 Jun 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
08 Jun 2026, 16:10:54 UTC
Prior SEC filing
06 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Tina Nova

Key filing fact

Tina Susan Nova filed Form 4 for Aurinia Pharmaceuticals Inc. (AUPH) on 08 Jun 2026.

Key facts

  • This page summarizes Tina Susan Nova's Form 4 filing for Aurinia Pharmaceuticals Inc. (AUPH).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 08 Jun 2026, 16:10.

Change

  • Previous filing in this sequence was filed on 06 Feb 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001302605 Primary reporting owner

Nova Tina Susan

Relationship
Director
Address
#140, 14315-118 AVENUE, EDMONTON, ALBERTA, CANADA
Signature
/s/ Tina Nova
Signature date
08 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AUPH transaction Derivative

Director Stock Option (right to buy)

Award

Transaction value
Shares
+23,931
Change %
Price
$0.000000*
Shares after
23,931
Date
04 Jun 2026
Ownership
Direct
Underlying class
Common Shares
Underlying amount
23,931
Exercise price
$15.67
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The options shall vest one year from date of grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .